Ligand News and Research

RSS
Research findings open door to development of new therapies for lymphomas, leukemias

Research findings open door to development of new therapies for lymphomas, leukemias

Anti-Dengue drug candidates demonstrate efficacy in preliminary cell culture studies

Anti-Dengue drug candidates demonstrate efficacy in preliminary cell culture studies

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Amgen announces European approval of Prolia

Amgen announces European approval of Prolia

Blocking the activity of death receptor can stop tumor growth: New research study

Blocking the activity of death receptor can stop tumor growth: New research study

Scientists develop DNA-vaccine that restricts supply of blood to tumours

Scientists develop DNA-vaccine that restricts supply of blood to tumours

Ligand Pharmaceuticals secures milestone and royalty interest in IL-9 antibody program

Ligand Pharmaceuticals secures milestone and royalty interest in IL-9 antibody program

European researchers define research priorities in biogerontology

European researchers define research priorities in biogerontology

Researchers discover key gene that promotes development of common kidney cancer

Researchers discover key gene that promotes development of common kidney cancer

New study uses NMR in drug design

New study uses NMR in drug design

KemPharm enters Supply Agreement with Johnson Matthey for KP201 hydrocodone prodrug for acute pain

KemPharm enters Supply Agreement with Johnson Matthey for KP201 hydrocodone prodrug for acute pain

Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor

Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor

Researchers develop new approach to immunotherapy of cancer

Researchers develop new approach to immunotherapy of cancer

Key mechanisms for delivery of LNP-encapsulated siRNAs to the liver

Key mechanisms for delivery of LNP-encapsulated siRNAs to the liver

Scripps Research Institute awarded grant to design assays for exploring potential target for obesity, Type 2 diabetes

Scripps Research Institute awarded grant to design assays for exploring potential target for obesity, Type 2 diabetes

Pieris AG announces preclinical data for proprietary PRS-110 Anticalin compound

Pieris AG announces preclinical data for proprietary PRS-110 Anticalin compound

REGN reports net loss of $30.5M for first-quarter 2010

REGN reports net loss of $30.5M for first-quarter 2010

NWO awards 31 grants in Investment Subsidy NWO Medium programme

NWO awards 31 grants in Investment Subsidy NWO Medium programme

Investment report on Somaxon Pharmaceuticals from MicroStockProfit.com

Investment report on Somaxon Pharmaceuticals from MicroStockProfit.com

AVEO Pharmaceuticals reports net loss of $14.4 million for first-quarter 2010

AVEO Pharmaceuticals reports net loss of $14.4 million for first-quarter 2010